e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Physiotherapy techniques: from evaluation to rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)?
T. Troosters, F. Pitta, V. Probst, G. Celis, M. Spruit, R. Gosselink, M. Decramer (Leuven, Belgium)
Source:
Annual Congress 2005 - Physiotherapy techniques: from evaluation to rehabilitation
Session:
Physiotherapy techniques: from evaluation to rehabilitation
Session type:
Thematic Poster Session
Number:
1166
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Troosters, F. Pitta, V. Probst, G. Celis, M. Spruit, R. Gosselink, M. Decramer (Leuven, Belgium). Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)?. Eur Respir J 2005; 26: Suppl. 49, 1166
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Distribution of leg muscle weakness in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008
The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006
Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
The relationship between proximal limb and trunk muscle strength and respiratory parameters in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Vitamin D receptor genotypes influence quadriceps strength in COPD
Source: Annual Congress 2007 - Pathophysiology of respiratory muscles
Year: 2007
Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016
Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
The impact of systemic corticosteroids on respiratory muscle function in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 505s
Year: 2005
Handgrip strength reflects excersice capacity and systemic inflammation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Risk of severe exacerbations in COPD patients associates with mass of intercostal and abdominal muscles: a CT scan study
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006
Resistance versus endurance training in patients with COPD and peripheral muscle weakness
Source: Eur Respir J 2002; 19: 1072-1078
Year: 2002
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006
Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study
Source: Eur Respir J 2011; 38: 781-788
Year: 2011
Strategies of muscle training in very severe COPD patients
Source: Eur Respir J 2011; 38: 971-975
Year: 2011
Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept